Scarica l'app Stockscreener
46.45
5.14%
-2.515
Janux Therapeutics Inc Azioni (JANX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
49.13%
1.252
|
2.461 | 2.517 | 1.057 | 2.048 |
Operating Expenses
|
15.14%
21.41
|
18.60 | 18.33 | 21.80 | 22.33 |
| Benefits Costs and Expenses |
12.61%
16.01
|
14.22 | 14.09 | 18.57 | 19.51 |
| Costs And Expenses |
12.61%
16.01
|
14.22 | 14.09 | 18.57 | 19.51 |
| Operating Income/Loss |
24.94%
-20.16
|
-16.14 | -15.81 | -20.75 | -20.28 |
| Nonoperating Income/Loss |
23.34%
5.401
|
4.379 | 4.245 | 3.24 | 2.822 |
| Income/Loss From Continuing Operations Before Tax |
25.53%
-14.76
|
-11.76 | -11.57 | -17.51 | -17.46 |
| Income/Loss From Continuing Operations After Tax |
25.53%
-14.76
|
-11.76 | -11.57 | -17.51 | -17.46 |
|
Net Income/Loss
|
25.53%
-14.76
|
-11.76 | -11.57 | -17.51 | -17.46 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,357%
49.05
|
0.8989 | 45.71 | 41.84 | 41.76 |
| Diluted Average Shares |
5,357%
49.05
|
0.8989 | 45.71 | 41.84 | 41.76 |
| Basic Earnings Per Share |
25.00%
-0.30
|
-0.24 | -0.25 | -0.42 | -0.42 |
| Diluted Earnings Per Share |
25.00%
-0.30
|
-0.24 | -0.25 | -0.42 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):